Makes wearable cardioverter defibrillators for patients at risk of sudden cardiac arrest.
Jul 2026Revenue $107M/yrExpenses $250M/yr
No trendCash runway ≈ 1.6 years from Jul 2026
Figures by year
When will Kestra Medical Technologies be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jul 2026, revenue was $107M and expenses $250M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Apr 2026 | $95.1M | $230M | −$135M |
| Apr 2025 | $59.8M | $166M | −$106M |
| Apr 2024 | $27.8M | $113M | −$85.1M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.